Research Funding

Grant Title Grantor Amount Award Date
Lisa M. Frenkel, MD
"P1066" - MK-0518-022 (Brooks Jackson) Johns Hopkins University $11,447 annual direct costs Jan. 1, 2015 - Dec. 31, 2015
Alpana Amalkant Waghmare, MD
Viral and Host Biomarkers of Human Rhinovirus Disease Severity in Transplantation National Institutes of Health, National Institute of Allergy and Infectious Diseases $162,988 Dec. 11, 2014 - Nov. 30, 2019
Lisa M. Frenkel, MD
Administrative Supplement (PEPFAR) - R01 AI100037 NIH $436,863 annual direct costs July 15, 2014 - May 31, 2016
Lakshmi Rajagopal, PhD
Role of an ornithine rhamnolipid pigment in GBS virulence - R01 AI112619 NIH/NIAID $250,000 annual direct costs July 1, 2014 - June 30, 2019
Claudia Syueping Crowell, MD
Improving Neurodevelopmental Outcomes of HIV-Infected Children in Kenya Seattle Childrens Hospital July 1, 2014 - June 30, 2016
Alpana Amalkant Waghmare, MD
Viral factors of disease severity in human rhinovirus infection following transplantation Seattle Childrens Research Institute $44,773 July 1, 2014 - June 30, 2016
Ann J. Melvin, MD
International and Domestic Pediatric and Maternal HIV Studies Coordinating Center NIH $220,081 June 1, 2014 - May 31, 2015
Lisa M. Frenkel, MD
"Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART" - R01 HD080460 (PI: John-Stewart) NIH $11,393 subcontract annual direct costs May 1, 2014 - April 30, 2019
Lisa M. Frenkel, MD
"A rapid point-of-treatment diagnostic assay for HIV-resistance to 1st-line ART" - R01 AI110375 NIH $250,000 annual direct costs May 1, 2014 - April 30, 2019
Lisa M. Frenkel, MD
"Mechanisms of Formation and Persistence of Active HIV Reservoirs" - R01 AI111806 (PI: Mullins) NIH $114,390 subcontract annual direct costs April 1, 2014 - March 31, 2019
Jane L. Burns, MD
Prevalence and Clinical Significance of S. aureus small-colony variants - HOFFMA14A0 (PI: Burns and Hoffman) Cystic Fibrosis Foundation Therapeutics $109,481 Burns annual direct costs April 1, 2014 - March 31, 2017
Timothy Rose, PhD
Point-of-care diagnosis and surveillance of known and emerging influenza viruses - R01 AI111303 NIH/NIAID $855,731 annual directs March 15, 2014 - Feb. 28, 2019
Thor A. Wagner, MD
"Mechanisms of Formation and Persistence of Active HIV Reservoirs" - R01 AI111806 (PI: Mullins) NIH $10,720 subcontract annual direct costs March 15, 2014 - Feb. 28, 2019
Lisa M. Frenkel, MD
"International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group" Virology Lab - UM1 AI106716 (PI: Aldrovandi) NIH $95,547 annual direct costs Jan. 1, 2014 - Nov. 30, 2020
Heather B. Jaspan, MD, PhD
"Intestinal microbiota, immune activation and vaccine responsiveness of the HIV-exposed infant" (Co-PI with Cameron) Canadian Institutes of Health Research $100,000 2014 - 2015
Jane L. Burns, MD
Long Term Outcomes after Eradication of Pseudomonas aeruginosa among Children Enrolled in the EPIC Clinical Trial - #CTBM100CUSNC01T (PI: Hamblett) Novartis $34,426 annual direct costs Dec. 15, 2013 - Dec. 15, 2015
Matthew P. Kronman, MD, MSCE
Translational Research Ignition Projects Program SCH Center for Clinical and Translational Research $26,015 direct support Nov. 4, 2013 - Sept. 30, 2014
Claudia Syueping Crowell, MD
A Pilot Study of the Effect of the Mediational Intervention of Sensitizing Caregivers (MISC) on Neurodevelopment in HIV-infected Children in Kenya Seattle Childrens Hospital Oct. 1, 2013 - March 31, 2015
Lakshmi Rajagopal, PhD
Environmental signals that regulate GBS virulence - R21 AI109222 NIH/NIAID $150,000 annual direct costs Sept. 1, 2013 - Aug. 31, 2015
Jane L. Burns, MD
Proof of Principle Evaluation of IV Gallium Nitrate in Patients with Cystic Fibrosis - UM1 HL119073 (PI: Goss) $55,495 Burns' annual direct costs Sept. 1, 2013 - June 30, 2016
Matthew P. Kronman, MD, MSCE
Clinical Research Scholars Program SCH Center for Clinical and Translational Research $51,510 direct support July 1, 2013 - June 30, 2015
Lakshmi Rajagopal, PhD
Eukaryotic-type signaling mediates two-component regulation of GBS virulence - R56 AI070749-06A1 NIH/NIAID $247,362 annual direct costs June 11, 2013 - Dec. 31, 2014
Lisa M. Frenkel, MD
"University of Washington Center for AIDS Research" (CFAR) - P30 AI027757 (PI: Holmes) NIH $11,528 annual direct costs June 1, 2013 - May 31, 2016
Marta Bull, PhD
"University of Washington Center for AIDS Research" (CFAR) - P30 AI027757 (PI: King Holmes) NIH $11,528 subcontract annual direct costs June 1, 2013 - May 31, 2015
Lisa M. Frenkel, MD
"Detection of HIV drug resistance mutations using highly multiplexed ligation/qPCR assays" NIH March 31, 2013 - April 1, 2014
Janet A. Englund, MD
Clinical Significance of rhinovirus Seattle Children's Hospital Clinical Translational Research Center Dec. 20, 2012 - Sept. 30, 2013
Danielle M. Zerr, MD, MPH
Frequency and Duration of Intestinal Carriage and Bacterial Evolution Over Time in Pediatric Patients with Resistant Enterobacteriaceae Infections Children's Research Institute/Translational Research Ignition Projects Program $50,000 Dec. 12, 2012 - Sept. 30, 2013
Jane L. Burns, MD
A Phase 2, Randomized, Double Blind, Placebo-Controlled, Repeat-Dose Study of KB001 A in Subjects with Cystic Fibrosis Infected with Pseudomonas aeruginosa KaloBios Pharmaceuticals, Inc. $45,032 total direct costs Oct. 10, 2012 - Dec. 31, 2014
Lisa M. Frenkel, MD
"International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group" NIH Sept. 1, 2012 - Dec. 31, 2013
Danielle M. Zerr, MD, MPH
Impact of chlorhexidine bathing on reducing infections in children with cancer NIH/NCI $$410,000 Aug. 1, 2012 - May 31, 2017
Lakshmi Rajagopal, PhD
GBS mediated in utero fetal injury - R01 AI100989 (Co-PI with Kristina Adams Waldorf) NIH/NIAID $499,906 annual direct costs July 1, 2012 - June 30, 2017
Lisa M. Frenkel, MD
"Drug-resistance testing in Kenya to improve ART suppression of HIV replication" (PEPFAR) - R01 AI100037 NIH $695,729 annual direct costs June 3, 2012 - May 31, 2016
Janet A. Englund, MD
RSV surveillance and antibody levels in Southeast Asia PATH May 2012 - June 2014
Lisa M. Frenkel, MD
"Academic Pediatric Infectious Disease" - T32 HD007233 NIH $277,930 annual direct costs May 1, 2012 - April 30, 2017
Jane L. Burns, MD
Lab Services - Grifols Protocol# T6005-201 Grifols Therapeutics, Inc. April 10, 2012 - April 10, 2014
Jane L. Burns, MD
A three week dose escalation, randomized, double-blind, placebo controlled trial to assess the safety and tolerability of inhaled alpha-1 HC in subjects with cystic fibrosis Grifols Therapeutics, Inc. April 10, 2012 - April 10, 2014
Scott J. Weissman, MD
Differences in infecting and colonizing Enterobacteriaceae from short-course vs standard therapy of pediatric UTI - R21AI099930 NIH/NIAID $125,000 annual DC April 1, 2012 - Feb. 28, 2015
Jane L. Burns, MD
Persistent MRSA Eradication Protocol - #PMEP11K1 (PI: Dasenbrook) CFFT $37,240 subcontract annual direct costs Jan. 1, 2012 - Dec. 31, 2014
Heather B. Jaspan, MD, PhD
"Myeloid-derived Suppressor cells (MDSC) suppress infant immune responses" (PI: Horton) (Jaspan: South African PI) NICHHD/NIH $180,000 total subcontract 2012 - 2017
Heather B. Jaspan, MD, PhD
"Innate, Adaptive and Mucosal Immune Responses in HIV-1 Exposed Uninfected Infants: A Human Model to Understand Correlates of Immune Protection" Canadian HIV Vaccine Initiative/ Canadian Institutes for Health Research $577,406 for Jaspan 2012 - 2016
Thor A. Wagner, MD
Systematic High-Throughput Screening of B-cell Repertoires to Identify Antibodies Specific for HIV-Infected Cells Bill and Melinda Gates Foundation $ Nov. 1, 2011 - April 30, 2013
Janet A. Englund, MD
New Vaccine Surveillance Network CDC Aug. 1, 2011 - July 31, 2015
Timothy Rose, PhD
Oral pathogenesis and host interactions of KSHV infection - P01 DE021954 NIH/NIDCR $993,231 + $120,000 annual directs June 7, 2011 - April 30, 2016
Serge Barcy, PhD
Oral pathogenesis and host interactions of KSHV infection - P01 DE021954 (Rose) NIH/NIDCR $993,231 annual directs June 1, 2011 - April 30, 2016
Claudia Syueping Crowell, MD
Resistance in HIV-1 non-subtype B infected children failing first-line antiretroviral therapy. Thrasher Early Career Award June 2011 - Aug. 2013
Jane L. Burns, MD
Non-invasive detection of Pseudomonas aeruginosa in the exhaled breath of individuals with CF Life Science Discovery Fund (Washington State) May 1, 2011 - Oct. 25, 2012
Lisa M. Frenkel, MD
"HIV-1 evolution in the female genital tract and trafficking in the blood" - R01AI091550. NIH/NIAID $254,817 annual direct costs Jan. 21, 2011 - Dec. 31, 2015
Marta Bull, PhD
"HIV-1 evolution in the female genital tract and trafficking in the blood" - R01 AI091550 (PI: Frenkel) NIH $254,817 annual direct costs Jan. 21, 2011 - Dec. 31, 2015
Heather B. Jaspan, MD, PhD
K08 "Assessing feeding practices, immune activation, and HIV risk in South African infants" NIH/NIAID $100,000 per year 2011 - 2016
Lisa M. Frenkel, MD
"Immunologic and Virologic Events in Early HIV Infection" (SEAPIP) - P01 AI057005 (Mullins). NIH $101,000 annual direct costs July 15, 2010 - June 30, 2015
Jane L. Burns, MD
Translational Research Center to Expedite Novel Therapies in Cystic Fibrosis - P30 DK089507 (PI: Ramsey & Greenberg) NIH $25,749 Burns' annual direct costs July 6, 2010 - May 31, 2015
Danielle M. Zerr, MD, MPH
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections NIH/NIAID $437,668 July 1, 2010 - June 30, 2014
Jane L. Burns, MD
A pharmacokinetic and safety study of IV gallium nitrate in CF patients (GA001) NIH (PI: Goss, C) July 1, 2010 - June 30, 2012
Claudia Syueping Crowell, MD
Phenotypic and Genotypic Resistance in HIV-1 non-Subtype B in Children Failing First-Line Antiretroviral Therapy Colman Family Grant July 2010 - June 2012
Jane L. Burns, MD
Mechanism of Azithromycin Activity in Pseudomonas Infections Mechanism of Azithromycin Activity in Pseudomonas Infections June 15, 2010 - May 31, 2012
Scott J. Weissman, MD
Resistance and relatedness: Molecular features of Klebsiella pneumoniae as a colonizer and pathogen in pediatric patients in Seattle, WA Institute of Translational Health Sciences/UW June 3, 2010 - April 30, 2012
Scott J. Weissman, MD
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections - R01 AI083413 (Co-PI with Zerr) NIH/NIAID $420,236 annual DC June 1, 2010 - May 31, 2015
Jane L. Burns, MD
Does hypermutability in B. cenocepacia increase virulence in CF? Cystic Fibrosis Foundation April 1, 2010 - March 31, 2013
Jane Burns, MD
Safety and efficacy of aztreonam Gilead Sciences Jan. 12, 2010 - Jan. 12, 2015
Thor A. Wagner, MD
HIV Persistence Despite Therapy due to Proliferation of Infected Cells Fraternal Order of Eagles Oct. 1, 2009 - Sept. 30, 2014
Jane Burns, MD
Pseudomonas aeruginosa adaptation during early cystic fibrosis infection and treatment NIH $ Sept. 11, 2009 - July 31, 2014
Danielle Zerr, MD, MPH
Impact of Daily Bathing with Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit Sage Products, Inc. $100,000.00 Sept. 1, 2009 - July 31, 2012
Danielle Zerr, MD, MPH
HHV-6 and CNS disease following stem cell transplant NIH/NIAID $278,321.00 Sept. 1, 2009 - June 30, 2010
Danielle Zerr, MD, MPH
National surveillance of emerging MDR in pediatric Enterobacteriaceae infections NIH/NIAID $378,005.00
Lisa M. Frenkel, MD
"Quantification and Dynamics of HIV-1 Drug-Resistant Mutants by Pyrosequencing" NIH July 1, 2009 - June 30, 2013
Timothy Rose, PhD
POC molecular method for detection of known and emerging respiratory viruses NIH/NIDCR $300,885.00 July 1, 2009
Matthew P. Kronman, MD, MSCE
Young Investigator Grant Academic Pediatric Association / AHRQ $10,000 direct support July 1, 2009 - June 30, 2010
Matthew P. Kronman, MD, MSCE
National Research Service Award (NRSA) Institutional Training Grant Childrens Hospital of Philadelphia Department of Pediatrics July 1, 2009 - June 30, 2011
Danielle Zerr, MD, MPH
Infection Control of Keyboards (ICK) Study: A Randomized, Blinded, Multi-Center Study of Ultraviolet Light Decontamination Vioguard LLC $114,000.00 June 1, 2009 - Jan. 31, 2011
Janet A. Englund, MD
Operation of a Facility for the Study of Infectious Agents, Vaccines, and Antimicrobials NIH/ Subsite of Johns Hopkins April 7, 2009 - April 6, 2013
Lisa M. Frenkel, MD
"Low-frequency HIV-1 Drug Resistance Mutations in Primary HIV-1 Infection" - R01 AI078802 (Steckler) NIH $61,594 annual direct costs April 1, 2009 - June 30, 2015
Janet A. Englund, MD
Maternal Immunization to protect the Mother and Neonate Bill and Melinda Gates Fndn Jan. 2009 - Dec. 2014
Thor Wagner, MD
Novel microcapillary immunoassay methodology to enable point-of-care infant HIV-1 diagnosis Seattle Children’s Hospital Jan. 1, 2009
Danielle Zerr, MD, MPH
Emerging MDR in pediatric Enterobacteriaceae infections CCTR Pediatric Pilot Award $20,000.00 Dec. 1, 2008 - Nov. 30, 2009
Lisa M. Frenkel, MD
"Effect of Lactobacillus on Genital HIV-1 RNA and DNA Shedding in Women" NIH Sept. 30, 2008 - Aug. 31, 2010
Thor Wagner, MD
Persistent HIV-1 Replication in the Respiratory Tract Despite Antiretroviral Treatment NIH-NIAID Sept. 1, 2008 - Nov. 30, 2013
Thor A. Wagner, MD
Improving Pediatric HIV-1 Diagnostics in an Effort to Avoid Antiretroviral Treatment Failure in Tamilnadu, India Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene July 1, 2008 - June 30, 2014
Ann Melvin, MD
Bone mineral density in tenofovir-exposed infants and young children Gilead Sciences Phase4 program $47,943.00 June 23, 2008 - May 30, 2011
Scott J. Weissman, MD
Multi-drug resistance and virulence patterns in canine and feline urinary E. coli American College of Veterinary Medicine Jan. 1, 2008 - March 31, 2011
Ann Melvin, MD
International and Domestic Pediatric and Maternal HIV Studies Coordinating Center NIH $659,107.00 Dec. 16, 2007 - May 31, 2014
Lisa M. Frenkel, MD
"International and Domestic Pediatric and Maternal HIV Studies Coordinating Center" - NO1-DK-8-0001 (Melvin). NIH $11,360 annual direct costs Dec. 16, 2007 - Nov. 30, 2015
Ann J. Melvin, MD
Supplement 3 R01 NIH Sept. 26, 2007 - May 30, 2011
Ann J. Melvin, MD
NIH Cooperative Agreement NIH Sept. 1, 2007 - May 31, 1917
Timothy Rose, PhD
Viral and cellular factors involved in KSHV entry in cells of the oral mucosa NIH/NIDCR $1,125,000.00 Aug. 15, 2007
Timothy Rose, PhD
Herpesvirus latency and reactivation in macaque models of human disease NIH/NCRR $1,680,995.00 July 1, 2007
Lisa M. Frenkel, MD
"International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group" NIH July 1, 2006 - May 31, 2013
Lisa M. Frenkel, MD
"Etiology of Mastitis in HIV-1 Infected Women" NIH Aug. 15, 2005 - July 31, 2009
Lisa M. Frenkel, MD
"Occurrence and Outcome of Dual HIV-1 Infection" - R37 AI047734 (Mullins) NIH $4,987 annual direct costs July 5, 2005 - March 31, 2016
Jane L. Burns, MD
Therapeutics Development Network Coordinating Center (CFFT Infrastructure 2014-2015) (PI: Ramsey) CFFT $11,443 Burns' annual direct costs April 1, 2005 - March 31, 2016
Ann Melvin, MD
Reservoirs of Drug-Resistant HIV-1 US-India Collaborative Research Supplement NIH $58,907.00 March 1, 2005 - Feb. 28, 2012
Lisa M. Frenkel, MD
"Reservoirs of Drug-Resistant HIV-1" NIH March 1, 2005 - Feb. 28, 2012
Lisa M. Frenkel, MD
"Does HIV Continue to Replicate in Lung Macrophages of Children on Effective Therapy?" The Foster Foundation Jan. 1, 2005 - Dec. 31, 2009
Sherilyn Smith, MD
Predoctoral Training in Primary Care HRSA $10,000 July 2004 - June 2006
Danielle Zerr, MD, MPH
HHV-6 and CNS disease following stem cell transplant NIH/NIAID $250,000.00 July 1, 2004 - June 30, 2011
Lisa M. Frenkel, MD
"Reservoirs of drug-resistant HIV-1" NIAID-NIH May 1, 2004 - April 30, 2006
Jane Burns, MD
Translational Therapeutics Development Center - #GIBSON09YO (PI: Gibson) Cystic Fibrosis Foundation Therapeutics $166,400 annual direct costs April 1, 2004 - Dec. 31, 2015
Lisa M. Frenkel, MD
"Pediatric HIV Clinical Trials Network" Nov. 1, 2003 - Oct. 31, 2008
Lisa M. Frenkel, MD
"Immunology and Molecular Virology of Acute HIV Infection; Core C: Specimen and Repository" NIH Sept. 30, 2003 - March 31, 2008
Danielle Zerr, MD, MPH
Viral Pathogens and First Time Seizures in the Setting of Illness Private Donation $60,000.00 June 30, 2003 - July 1, 2010
Jane L. Burns, MD
Therapeutic Development Center Microbiology Core Laboratory - #BURNS03Y3 Cystic Fibrosis Foundation Therapeutics $112,315 annual direct costs April 1, 2003 - Dec. 31, 2015
Lisa M. Frenkel, MD
"Adaptation of an OLA for detection of drug-resistant HIV-1 mutants to non-B subtypes" NIH; Center for AIDS Research March 1, 2003 - Feb. 29, 2004
Lisa M. Frenkel, MD
"HIV Pathogenesis and Shedding" NIH Sept. 15, 2002 - Aug. 31, 2006
Lisa M. Frenkel, MD
"A pilot study to evaluate a novel method to quantify mitochondrial integrity of leukocytes and red blood cells in cord and peripheral blood." Bristol Meyer Squibb April 1, 2002 - Dec. 31, 2003
Lisa M. Frenkel, MD
"Immunization by HIV Exposure During Chemoprophylaxis" NIH Sept. 1, 2001 - Sept. 29, 2009
Sherilyn Smith, MD
Disseminating a Virtual Problem-Based Learning Program: Project L.I.V.E. FIPSE/DOE $30,000 July 2001 - June 2003
Lisa M. Frenkel, MD
"Prevention of HIV resistance to nevirapine in pregnancy." Fogarty International Center, NIH July 1, 2001 - Sept. 30, 2008
Lisa M. Frenkel, MD
"Womens HIV-1 Pathogenesis Program Project" NIH April 1, 2001 - March 31, 2008
Lisa M. Frenkel, MD
"Viral Lymphocyte Dynamics in Children" The Foster Foundation Jan. 1, 2001 - Dec. 31, 2001
Lisa M. Frenkel, MD
"Pediatric AIDS Foundation Emergency Funds." Elizabeth Glaser Pediatric AIDS Foundation Jan. 1, 2001 - Dec. 31, 2001
Lisa M. Frenkel, MD
"Children Affected by AIDS Foundation" Jan. 1, 2001 - Dec. 31, 2001
Lisa M. Frenkel, MD
"Viral Lymphocyte Dynamics in Children " The Foster Foundation Jan. 1, 2000 - Dec. 31, 2000
Sherilyn Smith, MD
Early Pulmonary Host Defense in M. tuberculosis infection NIH/NHLBI $1,203,000 Sept. 1999 - Aug. 2001
Lisa M. Frenkel, MD
"Pediatric AIDS Clinical Trials Group" NIH Feb. 1, 1999 - Jan. 31, 2000
Lisa M. Frenkel, MD
"Pediatric AIDS Emergency Funds" Elizabeth Glaser Pediatric AIDS Foundation Jan. 1, 1999 - Dec. 31, 2000
Lisa M. Frenkel, MD
"Viral Lymphocyte Dynamics in Children" The Foster Foundation Dec. 19, 1998 - Dec. 31, 1999
Sherilyn Smith, MD
CHRC New Investigator Grant Dec. 1998 - Nov. 1999
Lisa M. Frenkel, MD
"Monitoring the emergence of HIV-1 resistance to antiretroviral drugs in Latin America." World Health Organization (WHO/UNAIDS) Oct. 1, 1998 - Oct. 1, 1999
Lisa M. Frenkel, MD
"Immunizing by Mucosal SIV Exposure during RT Inhibition" NIH Sept. 30, 1998 - Sept. 29, 2001
Sherilyn Smith, MD
Cytokines in the pulmonary host response to mycobacteria American Lung Association $50,000 July 1998 - July 2000
Glen S. Tamura, MD
R29 First Award 1998
Lisa M. Frenkel, MD
"Ryan White Titles I and IV" Seattle-King County Department of Public Health Aug. 1, 1997 - July 31, 2001
Lisa M. Frenkel, MD
"Pediatric AIDS Clinical Trials Group" NIH
Lisa M. Frenkel, MD
"Pediatric AIDS Clinical Trials Group" NIH
Lisa M. Frenkel, MD
"Transient HIV infection in infants." The Foster Foundation Dec. 19, 1996 - Dec. 18, 1998
Sherilyn Smith, MD
PIDS Fellowship Pediatric Infectious Diseases Society $70,000 July 1995 - June 1997
Glen S. Tamura, MD
Clinical Investigator Award (K08) 1994
Glen S. Tamura, MD
Children's Health Research Grant 1994
Charles Smith, PhD
Short Term Research Training in Pediatrics for Medical Students unknown $182,260.00 May 1, 1993
Lisa M. Frenkel, MD
"Pediatric AIDS Clinical Trials Group" NIH Feb. 28, 1992 - Feb. 28, 1997
Claudia Syueping Crowell, MD
International and Domestic Pediatric and Maternal HIV Studies Coordinating Center (Westat) Clinical trials site to advance the interruption of mother to infant HIV-1 transmission, and improve prevention and treatment of HIV-1 infection for children and adolescents internationally as well as within the United States. NIH